Christopher Richard Anzalone Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Richard Anzalone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Christopher Richard Anzalone for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Gift | G | 0.00 | 1,126 | 0 | 2,544,621 | 2.5 M to 2.5 M (-0.04 %) |
Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 6.15 | 28,274 | 173,885 | 800,033 | |
Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 4.75 | 12,236 | 58,121 | 828,307 | |
Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 6.15 | 28,274 | 173,885 | 2,545,747 | 2.5 M to 2.5 M (+1.12 %) |
Dec 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 4.75 | 12,236 | 58,121 | 2,517,473 | 2.5 M to 2.5 M (+0.49 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.01 | 38,676 | 77,739 | 840,543 | |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.01 | 16,324 | 32,811 | 879,219 | |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 71.61 | 4,003 | 286,655 | 2,505,237 | 2.5 M to 2.5 M (-0.16 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 70.87 | 5,880 | 416,716 | 2,509,240 | 2.5 M to 2.5 M (-0.23 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 69.80 | 12,067 | 842,277 | 2,515,120 | 2.5 M to 2.5 M (-0.48 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.27 | 16,726 | 1,125,158 | 2,527,187 | 2.5 M to 2.5 M (-0.66 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.01 | 38,676 | 77,739 | 2,543,913 | 2.5 M to 2.5 M (+1.54 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.97 | 16,324 | 1,109,542 | 2,505,237 | 2.5 M to 2.5 M (-0.65 %) |
Dec 10 2020 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.01 | 16,324 | 32,811 | 2,521,561 | 2.5 M to 2.5 M (+0.65 %) |